Probiotic supplementations, however, improved glycaemic parameters by reducing HOMA-IR, FBG, and fasting insulin, all of which are positive routes toward hepatoprotection against insulin resistance which plays important role in the pathogenesis of NAFLD (13). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.